Myocardial revascularization with miniaturized extracorporeal circulation versus off pump: Evaluation of systemic and myocardial inflammatory response in a prospective randomized study

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 5, 2009, Pages 1206-1212

  Formica, Francesco ^a   Broccolo, Francesco ^a   Martino, Antonello ^a   Sciucchetti, Jennifer ^a   Giordano, Vincenzo ^a   Avalli, Leonello ^b   Radaelli, Gianluigi ^b   Ferro, Orazio ^a   Corti, Fabrizio ^a   Cocuzza, Clementina ^a   Paolini, Giovanni ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; CYTOKINE; HEMOGLOBIN; INTERLEUKIN 6; LACTIC ACID; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; FEMALE; HEART MUSCLE; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTERMETHOD COMPARISON; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY DISEASE; EXTRACORPOREAL CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MIDDLE AGED; MINIATURIZATION; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64649098176     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.09.074     Document Type: Article

References (30)

1. Paparella D., Brister S.J., and Buchanan M.R. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 30 (2004) 1873-1881
2. Dixon B., Santamaria J., and Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 128 (2005) 229-236
3. Anselmi A., Abbate A., Girola F., Nasso G., Biondi-Zoccai G.G., Possati G., et al. Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg 25 (2004) 304-311
4. Haugen O., Farstad M., Kvalheim V., Hammersborg S., and Husby P. Intraoperative fluid balance during cardiopulmonary bypass: effects of different mean arterial pressures. Perfusion 22 (2007) 273-278
5. Kvalheim V.L., Rynning S.E., Farstad M., Haugen O., Nygreen E., Mongstad A., et al. Fluid overload during cardiopulmonary bypass is effectively reduced by a continuous infusion of hypertonic saline/dextran (HSD). Scand Cardiovasc J 25 (2007) 1-8
6. Haugen O., Farstad M., Kvalheim V., Bøe O., and Husby P. Elevated flow rate during cardiopulmonary bypass is associated with fluid accumulation. J Thorac Cardiovasc Surg 134 (2007) 587-593
7. Selnes O.A., Grega M.A., Bailey M.M., Pham L., Zeger S., Baumgartner W.A., et al. Neurocognitive outcomes 3 years after coronary artery bypass graft surgery: a controlled study. Ann Thorac Surg 84 (2007) 1885-1896
8. Korn-Lubetzki I., Oren A., Asher E., Dano M., Bitran D., Fink D., et al. Strokes after cardiac surgery: mostly right hemispheric ischemic with mild residual damage. J Neurol 254 (2007) 1708-1713
9. Morariu A.M., Loef B.G., Aarts L.P., Rietman G.W., Rakhorst G., van Oeveren W., et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 128 (2005) 2677-2687
10. Li S., Price R., Phiroz D., Swan K., and Crane T.A. Systemic inflammatory response during cardiopulmonary bypass and strategies. J Extra Corpor Technol 37 (2005) 180-188
11. Ascione R., Lloyd C.T., Gomes W.J., Caputo M., Bryan A.J., and Angelini G.D. Beating versus arrested heart revascularization: evaluation of myocardial function in a prospective randomized study. Eur J Cardiothorac Surg 15 (1999) 685-690
12. Ascione R., Lloyd C.T., Underwood M.J., Gomes W.J., and Angelini G.D. On-pump versus off-pump coronary revascularization: evaluation of renal function. Ann Thorac Surg 68 (1999) 493-498
13. Chernov V.I., Efimova N.Y., Efimova I.Y., Akhmedov S.D., and Lishmanov Y.B. Short-term and long-term cognitive function and cerebral perfusion in off-pump and on-pump coronary artery bypass patients. Eur J Cardiothorac Surg 29 (2006) 74-81
14. Ascione R., Ghosh A., Reeves B.C., Arnold J., Potts M., Shah A., et al. Retinal and cerebral microembolization during coronary artery bypass surgery: a randomized, controlled trial. Circulation 112 (2005) 3833-3838
15. Ascione R., Lloyd C.T., Underwood M.J., Lotto A.A., Pitsis A.A., and Angelini G.D. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69 (2000) 1198-1204
16. Caputo M., Reeves B.C., Rajkaruna C., Awair H., and Angelini G.D. Incomplete revascularization during OPCAB surgery is associated with reduced mid-term event-free survival. Ann Thorac Surg 80 (2005) 2141-2147
17. Ascione R., Caputo M., and Angelini G.D. Off-pump coronary artery bypass grafting: not a flash in the pan. Ann Thorac Surg 75 (2003) 306-313
18. Fromes Y., Gaillard D., Ponzio O., Chauffert M., Gerhardt M.F., Deleuze P., et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 22 (2002) 527-533
19. Immer F.F., Ackermann A., Gygax E., Stalder M., Englberger L., Eckstein F.S., et al. Minimal extracorporeal circulation is a promising technique for coronary artery bypass grafting. Ann Thorac Surg 84 (2007) 1515-1520
20. Agati S., Ciccarello G., Trimarchi E.S., Grasso D., Trimarchi G., Di Stefano S., et al. Extracorporeal circulation, optimized: a pilot study. Artif Organs 31 (2007) 377-383
21. Skrabal C.A., Steinhoff G., and Liebold A. Minimizing cardiopulmonary bypass attenuates myocardial damage after cardiac surgery. ASAIO J 53 (2007) 32-35
22. Wippermann J., Albes J.M., Hartrumpf M., Kaluza M., Vollandt R., Bruhin R., et al. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system. Eur J Cardiothorac Surg 28 (2005) 127-132
23. Mazzei V., Nasso G., Salamone G., Castorino F., Tommasini A., and Anselmi A. Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery. Circulation 116 (2007) 1761-1767
24. Wiesenack C., Liebold A., Philipp A., Ritzka M., Koppenberg J., Birnbaum D.E., et al. Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 28 (2004) 1082-1088
25. Remadi J.P., Rakotoarivelo Z., Marticho P., and Benamar A. Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra System or with a standard cardiopulmonary bypass. Am Heart J 151 (2006) 198
26. Beghi C., Nicolini F., Agostinelli A., Borrello B., Budillon A.M., Bacciottini F., et al. Mini-cardiopulmonary bypass system: results of a prospective randomized study. Ann Thorac Surg 81 (2006) 1396-1400
27. Remadi J.P., Rakotoarivello Z., Marticho P., Trojette F., Benamar A., Poulain H., et al. Aortic valve replacement with the minimal extracorporeal circulation (Jostra MECC System) versus standard cardiopulmonary bypass: a randomized prospective trial. J Thorac Cardiovasc Surg 128 (2004) 436-441
28. Castiglioni A., Verzini A., Pappalardo F., Colangelo N., Torracca L., Zangrillo A., et al. Minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement. Ann Thorac Surg 83 (2007) 586-591
29. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., et al. The proinflammatory CD14+ CD16+ DR++ monocytes are a major source of TNF. J Immunol 168 (2002) 3536-3542
30. Todd I., Radford P.M., Ziegler-Heibrock L., Ghaemmaghami A.M., Powell R.J., and Tighe P.J. Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 56 (2007) 4182-4188